My apologies Prosser, I had the reverse consolidation in my head. Not sure if there's anywhere near enough value to spin off the labs into separate company with shs. Especially today as patents don't have near the value they once did and EFL only has a handfull of them. Some companies are attempting (and failing) to sell their patent portfolios e.g. BB and QRTH. Splitting would keep the same cumulative market value unless the market is convinced the asset is better offf on its own. Which is doubtful IMO.